China's Sinopharm and Sinovac COVID-19 vaccines
protect against "severe hospitalization" caused by the Omicron variant,
the United Arab Emirates-based news outlet The National reported
Tuesday, quoting a World Health Organization (WHO) expert as saying. Abdi
Mahamud, the WHO's incident manager for the pandemic, said that "more
evidence is showing that Omicron is affecting the upper respiratory
tract, causing milder symptoms than previous variants." The UAE
recently approved the emergency use of a new recombinant protein vaccine
manufactured by Sinopharm, which will be used as a booster jab in the
country, the report said. The new Chinese vaccine demonstrated an
improved immune capacity against the new variant, "with a high safety
rate that allows rapid production and easy storage and distribution,"
according to the UAE's health ministry.
Sinopharm, Sinovac vaccines prevent severe hospitalization from Omicron: report
Editor:阮梓峰
Source:Xinhua
Updated:2022-01-06 17:01:08
Source:Xinhua
Updated:2022-01-06 17:01:08
Special
Contact
Welcome to English Channel! Any suggestion, welcome.Tel:0731-82965627
lisl@rednet.cn
zhouqian@rednet.cn